Found 8 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
cGMP-dependent protein kinase
() | BDBM340926
(3-(6-(3-chloro-5-fluorobenzyloxy)naphthalen-2- yl)...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(F)cc(Cl)c4)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C25H21ClFN5O/c1-14(2)32-25-22(24(28)29-13-30-25)23(31-32)18-4-3-17-10-21(6-5-16(17)9-18)33-12-15-7-19(26)11-20(27)8-15/h3-11,13-14H,12H2,1-2H3,(H2,28,29,30) | UniProtKB/SwissProt
GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2K077GQ |
More data for this Ligand-Target Pair | |
Calmodulin-domain protein kinase 1
(Toxoplasma gondii) | BDBM340926
(3-(6-(3-chloro-5-fluorobenzyloxy)naphthalen-2- yl)...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(F)cc(Cl)c4)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C25H21ClFN5O/c1-14(2)32-25-22(24(28)29-13-30-25)23(31-32)18-4-3-17-10-21(6-5-16(17)9-18)33-12-15-7-19(26)11-20(27)8-15/h3-11,13-14H,12H2,1-2H3,(H2,28,29,30) | PDB
UniProtKB/TrEMBL
GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR CO
US Patent
| Assay Description Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti... |
US Patent US10544104 (2020)
BindingDB Entry DOI: 10.7270/Q2D79DSF |
More data for this Ligand-Target Pair | |
Calmodulin-domain protein kinase 1
(Toxoplasma gondii) | BDBM340926
(3-(6-(3-chloro-5-fluorobenzyloxy)naphthalen-2- yl)...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(F)cc(Cl)c4)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C25H21ClFN5O/c1-14(2)32-25-22(24(28)29-13-30-25)23(31-32)18-4-3-17-10-21(6-5-16(17)9-18)33-12-15-7-19(26)11-20(27)8-15/h3-11,13-14H,12H2,1-2H3,(H2,28,29,30) | PDB
UniProtKB/TrEMBL
GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington Through its Center for Commercialization
US Patent
| Assay Description Most known kinase inhibitors bind in the ATP-binding pocket of the active site19,20. These inhibitors exploit many of the same hydrophobic contacts a... |
US Patent US9765037 (2017)
BindingDB Entry DOI: 10.7270/Q2B56MVC |
More data for this Ligand-Target Pair | |
Proto-oncogene tyrosine-protein kinase Src
(Homo sapiens (Human)) | BDBM340926
(3-(6-(3-chloro-5-fluorobenzyloxy)naphthalen-2- yl)...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(F)cc(Cl)c4)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C25H21ClFN5O/c1-14(2)32-25-22(24(28)29-13-30-25)23(31-32)18-4-3-17-10-21(6-5-16(17)9-18)33-12-15-7-19(26)11-20(27)8-15/h3-11,13-14H,12H2,1-2H3,(H2,28,29,30) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 107 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR CO
US Patent
| Assay Description Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti... |
US Patent US10544104 (2020)
BindingDB Entry DOI: 10.7270/Q2D79DSF |
More data for this Ligand-Target Pair | |
Calcium/calmodulin dependent protein kinase with a kinas domain and 4 calmodulin-like EF hands
(Cryptosporidium parvum (strain Iowa II)) | BDBM340926
(3-(6-(3-chloro-5-fluorobenzyloxy)naphthalen-2- yl)...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(F)cc(Cl)c4)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C25H21ClFN5O/c1-14(2)32-25-22(24(28)29-13-30-25)23(31-32)18-4-3-17-10-21(6-5-16(17)9-18)33-12-15-7-19(26)11-20(27)8-15/h3-11,13-14H,12H2,1-2H3,(H2,28,29,30) | UniProtKB/TrEMBL
GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 373 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2K077GQ |
More data for this Ligand-Target Pair | |
Calcium-dependent protein kinase 1
(Cryptosporidium parvum) | BDBM340926
(3-(6-(3-chloro-5-fluorobenzyloxy)naphthalen-2- yl)...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(F)cc(Cl)c4)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C25H21ClFN5O/c1-14(2)32-25-22(24(28)29-13-30-25)23(31-32)18-4-3-17-10-21(6-5-16(17)9-18)33-12-15-7-19(26)11-20(27)8-15/h3-11,13-14H,12H2,1-2H3,(H2,28,29,30) | UniProtKB/TrEMBL
GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 373 | n/a | n/a | n/a | n/a | n/a | n/a |
University of Washington Through its Center for Commercialization
US Patent
| Assay Description Two types of enzyme assays were developed to follow TgCDPK1 activity, a radiometric scintillation proximity assay measured the labeled γ-phospha... |
US Patent US9765037 (2017)
BindingDB Entry DOI: 10.7270/Q2B56MVC |
More data for this Ligand-Target Pair | |
Calmodulin-domain protein kinase 1, putative
(Cryptosporidium parvum (strain Iowa II)) | BDBM340926
(3-(6-(3-chloro-5-fluorobenzyloxy)naphthalen-2- yl)...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(F)cc(Cl)c4)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C25H21ClFN5O/c1-14(2)32-25-22(24(28)29-13-30-25)23(31-32)18-4-3-17-10-21(6-5-16(17)9-18)33-12-15-7-19(26)11-20(27)8-15/h3-11,13-14H,12H2,1-2H3,(H2,28,29,30) | PDB MMDB
UniProtKB/TrEMBL
B.MOAD GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 373 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR CO
US Patent
| Assay Description Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti... |
US Patent US10544104 (2020)
BindingDB Entry DOI: 10.7270/Q2D79DSF |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase ABL1
(Homo sapiens (Human)) | BDBM340926
(3-(6-(3-chloro-5-fluorobenzyloxy)naphthalen-2- yl)...)Show SMILES CC(C)n1nc(-c2ccc3cc(OCc4cc(F)cc(Cl)c4)ccc3c2)c2c(N)ncnc12 Show InChI InChI=1S/C25H21ClFN5O/c1-14(2)32-25-22(24(28)29-13-30-25)23(31-32)18-4-3-17-10-21(6-5-16(17)9-18)33-12-15-7-19(26)11-20(27)8-15/h3-11,13-14H,12H2,1-2H3,(H2,28,29,30) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.27E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR CO
US Patent
| Assay Description Inhibition of TgCDPK1 and CpCDPK1 was determined using a luminescent kinase assay which measures ATP depletion in the presence of the Syntide 2 pepti... |
US Patent US10544104 (2020)
BindingDB Entry DOI: 10.7270/Q2D79DSF |
More data for this Ligand-Target Pair | |